Reimar Fritzen

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Non-pharmacological Intervention, Preventive Medicine, Cardiovascular Disease +10

Levels of Autoantibodies against Human TSH Receptor Predict Relapse of Hyperthyroidism in Graves’ Disease

Mairin Schott, N. G. Morgenthaler, Reimar Fritzen et al. · Hormone and Metabolic Research · 2004 · 104 citations

Recurrent Graves, Active Gd, Allergy +14

Detecting TSH-Receptor Antibodies with the Recombinant TBII Assay: Technical and Clinical Evaluation

M. Schott, Joachim Feldkamp, C. Bathan et al. · Hormone and Metabolic Research · 2000 · 99 citations

<b>Megaoesophagus in a patient with autoimmune polyglandular syndrome Type II</b>

Reimar Fritzen, Stefan R. Bornstein, Werner A. Scherbaum · Clinical Endocrinology · 1996 · 20 citations

Evaluation of Safety and Efficacy of Rosiglitazone in the Treatment of HIV-Associated Lipodystrophy Syndrome

Torsten Feldt, Mark Oette, Arne Kroidl et al. · Infection · 2006 · 18 citations

Medicine, Hiv-associated Lipodystrophy Syndrome, Hiv +2